BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25060381)

  • 1. Reply: In regard to the TERISA trial.
    Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Yue P; Ben-Yehuda O; Belardinelli L; Chaitman BR
    J Am Coll Cardiol; 2014 Jul; 64(4):420-1. PubMed ID: 25060381
    [No Abstract]   [Full Text] [Related]  

  • 2. In regard to the TERISA trial.
    Golwala H
    J Am Coll Cardiol; 2014 Jul; 64(4):420. PubMed ID: 25060380
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes and coronary disease: a need for new therapies for an expanding disease burden.
    Lew WY; DeMaria AN
    J Am Coll Cardiol; 2013 May; 61(20):2046-7. PubMed ID: 23500323
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
    Kosiborod M; Arnold SV; Spertus JA; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Katz A; Jones PG; Olmsted A; Belardinelli L; Chaitman BR
    J Am Coll Cardiol; 2013 May; 61(20):2038-45. PubMed ID: 23500237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
    Arnold SV; Kosiborod M; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Spertus JA
    JAMA Intern Med; 2014 Aug; 174(8):1403-5. PubMed ID: 24887304
    [No Abstract]   [Full Text] [Related]  

  • 6. [The TERISA study].
    Galderisi M; Mafrici A
    G Ital Cardiol (Rome); 2013 Dec; 14(12):797-802. PubMed ID: 24336594
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on evidence for treatment with ranolazine in stable angina.
    Carbone F; Montecucco F; Mach F
    Swiss Med Wkly; 2013; 143():w13874. PubMed ID: 24163124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Symptomatic coronary heart disease therapy: ranolazine reduces frequency of angina in diabetic patients].
    MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):20. PubMed ID: 24260912
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
    Arnold SV; Kosiborod M; Li Y; Jones PG; Yue P; Belardinelli L; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):844-50. PubMed ID: 25249560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.
    Muhlestein JB; Grehan S
    Drugs R D; 2013 Sep; 13(3):207-13. PubMed ID: 23990357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ranolazine in the treatment of chronic stable angina].
    Gustapane M; Cardillo MT; Biasillo G; Della Bona R
    Clin Ter; 2012; 163(3):231-4. PubMed ID: 22964698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?
    Cocco G
    Expert Opin Pharmacother; 2012 Dec; 13(17):2429-32. PubMed ID: 23121536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
    Arnold SV; McGuire DK; Spertus JA; Li Y; Yue P; Ben-Yehuda O; Belardinelli L; Jones PG; Olmsted A; Chaitman BR; Kosiborod M
    Am Heart J; 2014 Oct; 168(4):457-465.e2. PubMed ID: 25262254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
    Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
    Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluative framework for phase II studies in patients with heart failure and preserved ejection fraction.
    Gheorghiade M; Vaduganathan M; Shah SJ
    JACC Heart Fail; 2013 Apr; 1(2):123-6. PubMed ID: 24621837
    [No Abstract]   [Full Text] [Related]  

  • 16. Ranolazine--a nicely timed new medical therapy for stable angina.
    Jackson G
    Int J Clin Pract; 2007 Jul; 61(7):1063. PubMed ID: 17577287
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
    Kohn CG; Parker MW; Limone BL; Coleman CI
    Am J Cardiol; 2014 Apr; 113(8):1306-11. PubMed ID: 24560062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranolazine: a novel therapeutic option in chronic stable angina.
    Jose J; Jimmy B; Saravu K; Shastry BA
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):596-9. PubMed ID: 18604102
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angina pectoris. Ranolazine is effective in myocardial ischemia therapy].
    MMW Fortschr Med; 2013 Oct; 155(18):74-5. PubMed ID: 24288929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ranolazine--new treatment of chronic stable angina pectoris].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Dec; 171(50):3705-7. PubMed ID: 20003868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.